MDUFMA Guidance Forecast: E-Labeling, Appeals, GMP Inspections
This article was originally published in The Gray Sheet
Executive Summary
Legal concerns raised by FDA's Office of Chief Counsel likely will delay issuance of a planned Sec. 301 guidance, according to MDUFMA Implementation Director Joanne Less, PhD